Loading...

New disaster communications system for Japan's hospitals

Image

15-Dec-15 Japan's government will begin developing a new communications service to facilitate the transportation of patients to core hospitals in times of disaster. The move comes after it was found that many core disaster medical centers were not equipped with satellite data communications systems, potentially causing problems if they had to accept patients after a major disaster. [image: The Yomiuri Shimbun]

Read More

Japan finances USD104 mn to help Vietnam build 10 hospitals

Image

10-Dec-15 The Japan International Cooperation Agency (JICA) has provided Vietnam with USD104 mn to finance the construction of ten hospitals. Costing USD120 mn, they are also funded by ministry and local budgets. The projects have been implemented since 2012, and are expected to ease overload at central level hospitals, and improve surgery, emergency and intensive care services. [image: JICA]

Read More

Here's why East Asia could be in big trouble

Image

09-Dec-15 Many countries in East Asia now have to worry about losing as much as 15% of their working-age population by 2040, according to the World Bank. It said aging population and low fertility rates are to blame. Policies such as encouraging women to work, reforming pension schemes and shifting focus from hospital care to primary care are being recommended. [image: Zhang Peng / LightRocket / Getty Images]

Read More

Japan’s generics market woos Indian firms

Image

16-Nov-15 Japan, with sales of USD115, accounts for 10% of the global pharma market, compared with 38% for the US and 21% for Europe. Lupin is the only Indian company in Japan's generics market. But now Sun Pharmaceuticals is planning to acquire Novartis' Japanese drug portfolio. Other Indian generics makers, including Dr Reddy’s and Glenmark, are also exploring options. [image: Bloomberg]

Read More

Japan's drug regulator PMDA plans India office

Image

15-Oct-15 Japan's drug regulator, the Pharmaceuticals and Medical Devices Agency (PMDA), is set to open an India office soon. The move is expected to help Indian generic drug manufacturers, which have been seeking to increase their presence in Japan either through exports or by forging joint ventures with partners in that country. [image: The Economic Times]

Read More